Sofosbuvir (CAS 1190307-88-0) Market Research Report: Information by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2030 (Recession Impact Analysis)
ID : MRU_
75653 | Date :
Jan, 2023 | Pages :
160 | Region : Global |
Publisher : MRU
The Global Sofosbuvir (CAS 1190307-88-0) Market touched xxx million USD with a CAGR xx % from 2018-2022 around the world. In the future, it is predicted to reach xxx million USD in 2023 with a CAGR xx % from 2023 - 2030.
As the report focuses on global Sofosbuvir (CAS 1190307-88-0) Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
This report focuses on Sofosbuvir (CAS 1190307-88-0) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Sofosbuvir (CAS 1190307-88-0) market size by analysing historical data and future prospect.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies- Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
NIFTY LABS PVT LTD
DEAFARMA
Anhui HaiKang Pharmaceutical Co. Ltd
Haoyuan Chemexpress Co.Ltd
SMS Pharmaceuticals Limited
Beijing Kawin Technology Share-holding Co
Manus Aktteva Biopharma LLP
Hangzhou Longshine Bio-Tech Co
Tecoland
Sinobright Pharmaceutical Company Limited In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers: ≥ 98% Purity
< 98% Purity In Market segmentation by applications : 400mg Tablets
Others
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Sofosbuvir (CAS 1190307-88-0) Market for the forecast period 2023 - 2030?
• What are the driving forces in the Sofosbuvir (CAS 1190307-88-0) Market for the forecast period 2023 - 2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Sofosbuvir (CAS 1190307-88-0) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
Executive Summary
1 Industry Overview of Sofosbuvir (CAS 1190307-88-0)
1.1 Definition of Sofosbuvir (CAS 1190307-88-0)
1.2 Sofosbuvir (CAS 1190307-88-0) Segment by Type
1.2.1 Global Sofosbuvir (CAS 1190307-88-0) Production Growth Rate Comparison by Types (2018-2030)
1.2.2 ≥ 98% Purity
1.2.3 < 98% Purity
1.3 Sofosbuvir (CAS 1190307-88-0) Segment by Applications
1.3.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Comparison by Applications (2018-2030)
1.3.2 400mg Tablets
1.3.3 Others
1.4 Global Sofosbuvir (CAS 1190307-88-0) Overall Market
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue (2018-2030)
1.4.2 Global Sofosbuvir (CAS 1190307-88-0) Production (2018-2030)
1.4.3 North America Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2018-2030)
1.4.4 Europe Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2018-2030)
1.4.5 China Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2018-2030)
1.4.6 Japan Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2018-2030)
1.4.7 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2018-2030)
1.4.8 India Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2018-2030)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sofosbuvir (CAS 1190307-88-0)
2.3 Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
2.4 Industry Chain Structure of Sofosbuvir (CAS 1190307-88-0)
3 Development and Manufacturing Plants Analysis of Sofosbuvir (CAS 1190307-88-0)
3.1 Capacity and Commercial Production Date
3.2 Global Sofosbuvir (CAS 1190307-88-0) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Sofosbuvir (CAS 1190307-88-0)
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Sofosbuvir (CAS 1190307-88-0) Production and Capacity Analysis
4.2 Sofosbuvir (CAS 1190307-88-0) Revenue Analysis
4.3 Sofosbuvir (CAS 1190307-88-0) Price Analysis
4.4 Market Concentration Degree
5 Sofosbuvir (CAS 1190307-88-0) Regional Market Analysis
5.1 Sofosbuvir (CAS 1190307-88-0) Production by Regions
5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Production by Regions
5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Regions
5.2 Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
5.3 North America Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.3.1 North America Sofosbuvir (CAS 1190307-88-0) Production
5.3.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Sofosbuvir (CAS 1190307-88-0) Import and Export
5.4 Europe Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.4.1 Europe Sofosbuvir (CAS 1190307-88-0) Production
5.4.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Sofosbuvir (CAS 1190307-88-0) Import and Export
5.5 China Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.5.1 China Sofosbuvir (CAS 1190307-88-0) Production
5.5.2 China Sofosbuvir (CAS 1190307-88-0) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Sofosbuvir (CAS 1190307-88-0) Import and Export
5.6 Japan Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.6.1 Japan Sofosbuvir (CAS 1190307-88-0) Production
5.6.2 Japan Sofosbuvir (CAS 1190307-88-0) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Sofosbuvir (CAS 1190307-88-0) Import and Export
5.7 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.7.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Production
5.7.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Import and Export
5.8 India Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.8.1 India Sofosbuvir (CAS 1190307-88-0) Production
5.8.2 India Sofosbuvir (CAS 1190307-88-0) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Sofosbuvir (CAS 1190307-88-0) Import and Export
6 Sofosbuvir (CAS 1190307-88-0) Segment Market Analysis (by Type)
6.1 Global Sofosbuvir (CAS 1190307-88-0) Production by Type
6.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type
6.3 Sofosbuvir (CAS 1190307-88-0) Price by Type
7 Sofosbuvir (CAS 1190307-88-0) Segment Market Analysis (by Application)
7.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Application
7.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application (2018-2022)
8 Sofosbuvir (CAS 1190307-88-0) Major Manufacturers Analysis
8.1 Teva Pharmaceutical Industries Ltd
8.1.1 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.1.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
8.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.1.4 Main Business and Markets Served
8.2 DONG BANG FUTURE TECH & LIFE CO., LTD
8.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Product Introduction, Application and Specification
8.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.2.4 Main Business and Markets Served
8.3 NIFTY LABS PVT LTD
8.3.1 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.3.2 NIFTY LABS PVT LTD Product Introduction, Application and Specification
8.3.3 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.3.4 Main Business and Markets Served
8.4 DEAFARMA
8.4.1 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.4.2 DEAFARMA Product Introduction, Application and Specification
8.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.4.4 Main Business and Markets Served
8.5 Anhui HaiKang Pharmaceutical Co. Ltd
8.5.1 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.5.2 Anhui HaiKang Pharmaceutical Co. Ltd Product Introduction, Application and Specification
8.5.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.5.4 Main Business and Markets Served
8.6 Haoyuan Chemexpress Co.Ltd
8.6.1 Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.6.2 Haoyuan Chemexpress Co.Ltd Product Introduction, Application and Specification
8.6.3 Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.6.4 Main Business and Markets Served
8.7 SMS Pharmaceuticals Limited
8.7.1 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.7.2 SMS Pharmaceuticals Limited Product Introduction, Application and Specification
8.7.3 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.7.4 Main Business and Markets Served
8.8 Beijing Kawin Technology Share-holding Co
8.8.1 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.8.2 Beijing Kawin Technology Share-holding Co Product Introduction, Application and Specification
8.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.8.4 Main Business and Markets Served
8.9 Manus Aktteva Biopharma LLP
8.9.1 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.9.2 Manus Aktteva Biopharma LLP Product Introduction, Application and Specification
8.9.3 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.9.4 Main Business and Markets Served
8.10 Hangzhou Longshine Bio-Tech Co
8.10.1 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production Sites and Area Served
8.10.2 Hangzhou Longshine Bio-Tech Co Product Introduction, Application and Specification
8.10.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production, Revenue, Ex-factory Price and Gross Margin (2018-2022)
8.10.4 Main Business and Markets Served
8.11 Tecoland
8.12 Sinobright Pharmaceutical Company Limited
9 Development Trend of Analysis of Sofosbuvir (CAS 1190307-88-0) Market
9.1 Global Sofosbuvir (CAS 1190307-88-0) Market Trend Analysis
9.1.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size (Volume and Value) Forecast 2023 - 2030
9.2 Sofosbuvir (CAS 1190307-88-0) Regional Market Trend
9.2.1 North America Sofosbuvir (CAS 1190307-88-0) Forecast 2023 - 2030
9.2.2 Europe Sofosbuvir (CAS 1190307-88-0) Forecast 2023 - 2030
9.2.3 China Sofosbuvir (CAS 1190307-88-0) Forecast 2023 - 2030
9.2.4 Japan Sofosbuvir (CAS 1190307-88-0) Forecast 2023 - 2030
9.2.5 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Forecast 2023 - 2030
9.2.6 India Sofosbuvir (CAS 1190307-88-0) Forecast 2023 - 2030
9.3 Sofosbuvir (CAS 1190307-88-0) Market Trend (Product Type)
9.4 Sofosbuvir (CAS 1190307-88-0) Market Trend (Application)
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.